Cover image of the article: Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management

Image Credit:Hepat Mon

Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management

Authors

Mostafa shafiei1, Seyed Moayed Alavian1,*
1Baqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
*Corresponding Author: aqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah University of Medical Sciences Email: alavian@thc.ir

Hepatitis Monthly:Vol. 12, issue 2; e93033
Published online:Feb 29, 2012
Article type:Editorial
Received:May 06, 2019
Accepted:Feb 29, 2012
How to Cite:shafiei M, Alavian SM. Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management. Hepat Mon. 2012;12(2):e93033. doi: https://doi.org/10.5812/hepatmon.840

Abstract

Autoimmune hepatitis is a quite serious disease, and will get worse if not treated properly. AIH is a disease that needs to be managed under the supervision of a team of specialists, including at least one hepatologist or a gastroenterologist with an interest in liver disease, as well as a laboratory that can measure all serum autoantibodies with accurate titres. This article is highly recommended to hepatologists, gastroenterologists, virologists, general practitioners, and researchers who are interested in public health.

Please cite this paper as:
Shafiei M, Alavian SM. Autoimmune Hepatitis in Iran: What We Know, What We Don't Know and Requirements for Better Management. Hepat Mon. 2012;12(2):73-6. DOI: 10.5812/hepatmon.840

Keywordshepatitis

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

26
Dec
2004
Clinical characteristics of Autoimmune Hepatitis

Clinical characteristics of Autoimmune Hepatitis

D Roshandel,
MR Rezai Lashkajani,
A Hekmatdoost,
H Mohaghegh,
A Ghaziani,
H Sendi
,et al.

Roshandel D, Rezai Lashkajani M, Hekmatdoost A, Mohaghegh H, Ghaziani A, et al. Clinical characteristics of Autoimmune Hepatitis. Zahedan J Res Med Sci. 2004;6(4):e94987. doi:

2
May
2013
Autoimmune Hepatitis in Children: Experiences in a Tertiary Center

Autoimmune Hepatitis in Children: Experiences in a Tertiary Center

seyedMohsen Dehghani,
Mahmood Haghighat,
Mohammad-Hadi Imanieh,
Nasser Honar,
Amir-Masoud Negarestani,
Abdorrasoul Malekpour
,et al.

Dehghani S, Haghighat M, Imanieh M, Honar N, Negarestani A, et al. Autoimmune Hepatitis in Children: Experiences in a Tertiary Center. Inn J Pediatr. 2013;23(3):. doi:

1
Oct
2003
Hepatitis in Iran

Hepatitis in Iran

Seyed Moayed Alavian,
Behzad Einollahi,
Behzad Hajarizadeh,
Siamak Bakhtiari,
Mohsen Nafar,
Sadegh Ahrabi

Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, et al. Hepatitis in Iran. Hepat Mon. 2003;2(1):e92719. doi:

31
Jul
2012
Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran

Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran

Seyed Moayed Alavian,
Hossain Jabbari,
Nasser Ebrahimi Daryani,
Mohammad Torabi Nami

Alavian SM, Jabbari H, Ebrahimi Daryani N, Torabi Nami M. Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran. Hepat Mon. 2012;12(7):. doi: https://doi.org/10.5812/hepatmon.6679

30
Sep
2011
Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran

Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran

Seyed Moayed Alavian,
Kamran B Lankarani,
Seyed Hossein Aalaei-Andabili,
Ali Pouryasin,
Nasser Daryani,
Mohsen Nasiritoosi
,et al.

Alavian SM, B Lankarani K, Aalaei-Andabili SH, Pouryasin A, Daryani N, et al. Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran. Hepat Mon. 2011;11(9):e93018. doi:

More by these authors

Mostafa shafieiPubMedScholar
Seyed Moayed AlavianPubMedScholar
Share
Cited by
Metrics